Meningococcal Vaccine Market Driven by Increasing Demand in Developing Countries | Registering a CAGR of 9.5% from 2019 to 2026. 

As per the report published by Allied Market Research, the global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions. Key Takeaways: Asia-Pacific region is …

Meningococcal Vaccine Market Opportunities, Top Trends, Rising Demand, Emerging Growth, Business, Future Business Growth By 2022-2026

Increase in outbreaks of meningococcal disease, surge in immunization programs across the globe, and rise in research and development for vaccine technology propel the growth of the global meningococcal vaccine market. However, longer timelines required for vaccine production and high cost associated with the development of vaccines impede the market growth. On the other hand, …